Literature DB >> 26985866

Tripartite Motif Protein 72 Regulates the Proliferation and Migration of Rat Cardiac Fibroblasts via the Transforming Growth Factor-β Signaling Pathway.

Jianquan Zhao1, Han Lei.   

Abstract

BACKGROUND: The proliferation and migration of cardiac fibroblasts are critical for the progress of cardiac fibrosis. Tripartite motif protein 72 (Trim72), also known as MG53, mediates the dynamic process of membrane fusion and exocytosis in striated muscle. However, the role of Trim72 in the proliferation and migration of cardiac fibroblasts is unknown.
METHODS: In the present study, we used small interference RNA (siRNA) to silence Trim72 and then investigated the effects of Trim72 on cardiac fibroblast proliferation and migration, which were activated during cardiac remodeling after myocardial infarction. Cardiac fibroblasts were isolated from 2- to 3-day-old neonatal Sprague-Dawley rats and transfected with siRNA. A cell-counting assay was used to determine the proliferation of cardiac fibroblasts. A Boyden chamber assay was performed to determine the migration of cardiac fibroblasts.
RESULTS: Our study has, for the first time, demonstrated that Trim72 regulates the cell proliferation and migration of rat cardiac fibroblasts. Furthermore, the data from the gene expression profile microarray analysis indicate that Trim72 depletion can cause downregulation of the transforming growth factor (TGF)-β signaling pathway, suggesting that Trim72 regulates the proliferation and migration of cardiac fibroblasts probably via the TGF-β signaling pathway.
CONCLUSIONS: We have demonstrated that Trim72 might play a pivotal role in the proliferation of neonatal rat cardiac fibroblasts, which could be a potential target for the treatment of cardiac fibrosis. However, the involvement of other signaling pathways and factors in the formation of cardiac fibrosis cannot be excluded.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26985866     DOI: 10.1159/000443703

Source DB:  PubMed          Journal:  Cardiology        ISSN: 0008-6312            Impact factor:   1.869


  7 in total

1.  CYP2J2 metabolites, epoxyeicosatrienoic acids, attenuate Ang II-induced cardiac fibrotic response by targeting Gα12/13.

Authors:  Zuowen He; Yong Yang; Zheng Wen; Chen Chen; Xizhen Xu; Yanfang Zhu; Yan Wang; Dao Wen Wang
Journal:  J Lipid Res       Date:  2017-05-29       Impact factor: 5.922

Review 2.  The Pivotal Role of Mitsugumin 53 in Cardiovascular Diseases.

Authors:  Wenhua Jiang; Manling Liu; Chunhu Gu; Heng Ma
Journal:  Cardiovasc Toxicol       Date:  2020-10-01       Impact factor: 3.231

3.  Swimming Exercise Alleviated Insulin Resistance by Regulating Tripartite Motif Family Protein 72 Expression and AKT Signal Pathway in Sprague-Dawley Rats Fed with High-Fat Diet.

Authors:  Jie Qi; Bo Yang; Cailing Ren; Jian Fu; Jun Zhang
Journal:  J Diabetes Res       Date:  2016-10-24       Impact factor: 4.011

4.  MG53/CAV1 regulates transforming growth factor-β1 signaling-induced atrial fibrosis in atrial fibrillation.

Authors:  Meixia Zhang; Hechuan Wang; Xiaowen Wang; Mengjun Bie; Kai Lu; Hua Xiao
Journal:  Cell Cycle       Date:  2020-10-01       Impact factor: 4.534

Review 5.  Cardiac effects and clinical applications of MG53.

Authors:  Weina Zhong; Dathe Z Benissan-Messan; Jianjie Ma; Chuanxi Cai; Peter H U Lee
Journal:  Cell Biosci       Date:  2021-06-28       Impact factor: 7.133

6.  Analysis of Differentially Expressed Genes in Coronary Artery Disease by Integrated Microarray Analysis.

Authors:  Meenashi Vanathi Balashanmugam; Thippeswamy Boreddy Shivanandappa; Sivagurunathan Nagarethinam; Basavaraj Vastrad; Chanabasayya Vastrad
Journal:  Biomolecules       Date:  2019-12-25

7.  Prognostic Value of Circulating MG53 Levels in Acute Myocardial Infarction.

Authors:  Hongyang Xie; Zijun Yan; Shuo Feng; Tianqi Zhu; Zhengbin Zhu; Jingwei Ni; Jun Ni; Run Du; Jinzhou Zhu; Fenghua Ding; Shengjun Liu; Hui Han; Hang Zhang; Jiaxin Zhao; Ruiyan Zhang; Weiwei Quan; Xiaoxiang Yan
Journal:  Front Cardiovasc Med       Date:  2020-10-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.